Save information for later
Sign Up

Learn About Hygroma Cervical

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Hygroma Cervical Local Doctors?
Elite in Hygroma Cervical
Elite in Hygroma Cervical
92, Chung Shan North Road, 
TPQ, TW 

Chih-ping Chen practices in Taiwan. Chen is rated as an Elite expert by MediFind in the treatment of Hygroma Cervical. Their top areas of expertise are Trisomy 14 Mosaicism, Trisomy 18, Hygroma Cervical, and Trisomy 13.

Shaun T. O'leary
Advanced in Hygroma Cervical
Advanced in Hygroma Cervical

Aurora Neurosurgery

12500 Aurora Dr, 
Pleasant Prairie, WI 
Languages Spoken:
English

Shaun O'leary is a Neurosurgery provider in Pleasant Prairie, Wisconsin. Dr. O'leary is rated as an Advanced provider by MediFind in the treatment of Hygroma Cervical. His top areas of expertise are Sciatica, Complex Regional Pain Syndrome, Scoliosis, Gastrostomy, and Sacral Nerve Stimulation.

 
 
 
 
Learn about our expert tiers
Learn More
Aaron R. Plitt
Experienced in Hygroma Cervical
Neurosurgery
Experienced in Hygroma Cervical
Neurosurgery

Aurora Neuroscience Innovation

2801 W Kinnickinnic River Pkwy, Ste 680, 
Milwaukee, WI 
Languages Spoken:
English
Offers Telehealth

Aaron Plitt is a Neurosurgery provider in Milwaukee, Wisconsin. Dr. Plitt is rated as an Experienced provider by MediFind in the treatment of Hygroma Cervical. His top areas of expertise are Schwannoma, Acoustic Neuroma, Hydrocephalus, Neuroendocrine Tumor, and Endoscopy.

What are the latest Hygroma Cervical Clinical Trials?
A Modular Open Label, Signal Seeking, Phase II Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations (TARGET-VM)

Summary: Recent studies have demonstrated that growth of vascular malformations can be driven by genetic variants in one of 2 signalling pathways. Targeted drugs specific to these pathways have been developed and shown to be effective in treating cancer. This study will describe the effectiveness of (i) 48 weeks of alpelisib therapy for participants with slow-flow vascular malformations and a gene mutation...

Match to trials
Find the right clinical trials for you in under a minute
Get started